Chenodeoxycholic acid

Chenix (chenodiol) is a small molecule pharmaceutical. Chenodiol was first approved as Chenix on 1983-07-28. The pharmaceutical is active against bile acid receptor. In addition, it is known to target G-protein coupled bile acid receptor 1, fMet-Leu-Phe receptor, and nuclear receptor coactivator 2.